Meituan has a consensus price target of $18 based on the ratings of 1 analysts. The high is $18 issued by Barclays on March 28, 2022. The low is $18 issued by Barclays on March 28, 2022. The 1 most-recent analyst ratings were released by Barclays on March 28, 2022, respectively. With an average price target of $18 between Barclays, there's an implied -11.50% downside for Meituan from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Meituan (OTCPK:MPNGF) was reported by Barclays on March 28, 2022. The analyst firm set a price target for $18.00 expecting MPNGF to fall to within 12 months (a possible -11.50% downside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for Meituan (OTCPK:MPNGF) was provided by Barclays, and Meituan maintained their underweight rating.
There is no last upgrade for Meituan
There is no last downgrade for Meituan.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Meituan, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Meituan was filed on March 28, 2022 so you should expect the next rating to be made available sometime around March 28, 2023.
While ratings are subjective and will change, the latest Meituan (MPNGF) rating was a maintained with a price target of $29.00 to $18.00. The current price Meituan (MPNGF) is trading at is $20.34, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.